BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/8/2026 8:02:54 AM | Browse: 7 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 116025
Country China
Category Oncology
Manuscript Type Minireviews
Article Title Tailoring therapy through response evaluation: A new era in the management of locally advanced rectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Peng Wang, Ding-Chao Liu, Wei-Ping Wang and Ke Hu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 62476287
National Key Research and Development Program of China, Ministry of Science and Technology of the People’s Republic of China 2022YFC2402305
National High Level Hospital Clinical Research Funding 2025-PUMCH-A-028
Corresponding Author Ke Hu, MD, Professor, Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, No. 1 Shuaifuyuan Wangfujing, Dongcheng District, Beijing 100730, China. huke8000@126.com
Key Words Rectal cancer; Neoadjuvant therapy; Response evaluation; Tumor restaging; Minireview
Core Tip Neoadjuvant chemoradiotherapy followed by surgery is the standard treatment for locally advanced rectal cancer. Accurate post-treatment evaluation and restaging are crucial to guide subsequent treatment and prognosis prediction. While conventional methods such as imaging and endoscopy are widely used, their application is hampered by several limitations. Emerging technologies such as detection of circulating tumor DNA, multi-omics, and artificial intelligence offer new perspectives for cancer restaging. Novel therapies such as total neoadjuvant therapy and watch-and wait strategies require enhanced precision in response assessment to optimize individualized therapeutic decisions and improve prognosis in patients with locally advanced rectal cancer.
Citation Wang P, Liu DC, Wang WP, Hu K. Tailoring therapy through response evaluation: A new era in the management of locally advanced rectal cancer. World J Gastrointest Oncol 2026; In press
Received
2025-11-06 07:03
Peer-Review Started
2025-11-06 07:03
First Decision by Editorial Office Director
2025-12-02 07:35
Return for Revision
2025-12-02 07:35
Revised
2025-12-11 09:01
Publication Fee Transferred
2025-12-15 02:44
Second Decision by Editor
2026-01-08 02:47
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-08 08:02
Articles in Press
2026-01-08 08:02
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com